TNF and inflammatory bowel disease: Specifically, two of the currently available monoclonal antibodies for IBD treatment include antibodies against tumor necrosis factor-α (TNF-α), infliximab (IFX), a chimeric monoclonal antibody, and adalimumab (ADA), a fully human monoclonal antibody IBD [2].